Clinical Trials in Baltimore

Showing 5541-5560 of 17,842 trials

Eliminating the Need for Pancreas Biopsy Using Peripheral Blood Cell-free DNA

NCT04166149

Donor-derived cell-free DNA (dd-cfDNA) has shown promise as an early marker for cellular injury caused by rejection. dd-cfDNA changes may also indicate other injuries that lead to progressive decline in transplant organ function associated with, in the case of kidney transplantation, the presence of interstitial fibrosis (IF) and tubular atrophy (TA) seen in biopsy specimens. Here, we will study the utility of dd-cfDNA to predict rejection in pancreas and pancreas-kidney recipients.

Transplant;Failure,KidneyTransplant; Failure, PancreasRejection Acute Renal+1 more

University of Maryland, Baltimore140 participantsStarted Sep 2019

Washington D.C., District of Columbia, United States • Baltimore, Maryland, United States • Madison, Wisconsin, United States

COMPLETEDPhase 2< 1 mile

Trametinib in Treating Patients With Epithelioid Hemangioendothelioma That is Metastatic, Locally Advanced, or Cannot Be Removed by Surgery

NCT03148275

This phase II trial studies how well trametinib works in treating patients with epithelioid hemangioendothelioma that has spread to other places in the body (metastatic), nearby tissue or lymph nodes (locally advanced), or cannot be removed by surgery (unresectable). Trametinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

Locally Advanced Epithelioid HemangioendotheliomaMetastatic Epithelioid HemangioendotheliomaUnresectable Epithelioid Hemangioendothelioma

National Cancer Institute (NCI)44 participantsStarted Jun 2017

Phoenix, Arizona, United States • Scottsdale, Arizona, United States • Palo Alto, California, United States +33 more locations

Eliminating the Need for Pancreas Biopsy Using Peripheral Blood Cell-free DNA

Trametinib in Treating Patients With Epithelioid Hemangioendothelioma That is Metastatic, Locally Advanced, or Cannot Be Removed by Surgery

Find Trials by Condition in Baltimore

CGM/Clarity Use, Glycemic Control and Clinical Outcomes

Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction

Platelet Rich Plasma Versus Corticosteroids in Knee Osteoarthritis Pain

A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)

Covid-19 Long Haul Preventative and Health Promotion Care Clinical Trial Acceleration Program.

Sodium Thiosulfate for Treatment of Calcinosis Associated With Juvenile and Adult Dermatomyositis

MIRACLE of LIFE Study

Trial to Evaluate Efficacy and Safety of Apraglutide in SBS-IF

A Study of Abemaciclib (LY2835219) in Women With HR+, HER2+ Locally Advanced or Metastatic Breast Cancer

A Phase 1/2 Trial of SP-101 for the Treatment of Cystic Fibrosis (CF)

A Study of ZN-c3 in Patients With Ovarian Cancer

A Study Investigating the Safety, Tolerability and Efficacy of ASP7517 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia (AML) and Relapsed/Refractory Higher Risk Myelodysplastic Syndrome (MDS)

RCT of Brain Longitudinal Biomarker Study (OPT-Neuro RCT)

A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)

First in Human Study of M1069 in Advanced Solid Tumors

Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes

Real-World Evaluation of Eko Algorithms in a Point of Care Setting

A Study to Investigate the Clinical Benefit of Isatuximab in Combination With Bortezomib, Lenalidomide and Dexamethasone in Adults With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant